The Food and Drug Administration has scheduled meetings with advisors to discuss lifting restrictions on 12 unproven peptides, despite a 2023 ban. These drugs, often used without evidence for various health claims, are championed by anti-vaccine advocate Robert F. Kennedy Jr., who has no medical background but insists on their safety.

The meetings will occur over two days in July and again in February 2027. However, critics argue that the advisory panel lacks sufficient expertise, with only three voting members and six vacancies, including the chairperson’s post.

Peptides are chains of amino acids used to treat conditions or improve appearance, but many online versions lack clinical evidence. Kennedy has repeatedly promoted their use on podcasts and social media, claiming they helped his own injuries. He vows to end the FDA's 'war' on peptides, though his claims are met with skepticism.

Despite the push for scientific rigor, outside experts remain doubtful that these meetings will lead to significant changes in regulation. The debate highlights ongoing tensions between regulatory bodies and those advocating unproven treatments.